- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.
Advanced Enzyme received requests from five members of its founding group, who hold no shares, to be reclassified as public shareholders. This move, pending approvals, simplifies the shareholder structure, reflecting their current disassociation from the company.
Advanced Enzyme Technologies reported a Q1 FY27 revenue of INR 189.8 Cr (+2% YoY, -7% QoQ), noting a INR 10 Cr sales reversal impact. EBITDA came in at INR 51 Cr (-10% YoY) with 27% margins, and PAT at INR 38.6 Cr (-5% YoY). Management acknowledged a softer start due...
Advanced Enzyme Tech's board approved an open market buyback of shares worth up to ₹69.7 Cr, at a maximum price of ₹500 per share. This aims to acquire over 1.39 million shares, funded by internal resources. No new shares for 6 months post-buyback, reflecting capital management.
Advanced Enzyme Technologies' Board approved a buyback up to ₹ 69.7 Cr via the open market. The maximum price for the buyback is ₹ 500 per share, aiming to repurchase up to 13.94 lakh shares, representing about 1.24% of current paid-up equity. The offer is expected to open within 4...
ADVENZYMES' Board approved a share buyback of up to ₹69.70 Cr. The company will repurchase shares from the open market at a maximum price of ₹500 per share. The buyback offer opens on or before August 14, 2026, and is set to close by November 20, 2026, or earlier if...